Connection

Harry Clarke to Adrenergic alpha-Antagonists

Back to Details
This is a "connection" page, showing publications Harry Clarke has written about Adrenergic alpha-Antagonists.
Harry Clarke
Connection Strength
0.370
Adrenergic alpha-Antagonists
  1. Combination 5-alpha-reductase inhibitors and alpha-blockers for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curr Urol Rep. 2008 Jul; 9(4):291-4.
    View in: PubMed
    Score: 0.313
  2. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003 Dec 18; 349(25):2387-98.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.